Editorial: Combination Strategies in the Treatment of Melanoma

por Ascierto, Paolo Antonio
Publicado en Front Oncol (2016)

Immunotherapy in non-melanoma skin cancer: updates and new perspectives

por Ascierto, Paolo Antonio, Schadendorf, Dirk
Publicado en Drugs Context (2019)

Perspectives on COVID-19 and cancer immunotherapy: a review series

por Goldman, Jason D, Ascierto, Paolo Antonio
Publicado en J Immunother Cancer (2021)

IL-6 modulation for COVID-19: the right patients at the right time?

por Ascierto, Paolo Antonio, Fu, Binqing, Wei, Haiming
Publicado en J Immunother Cancer (2021)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy

por Ascierto, Maria Libera, Melero, Ignacio, Ascierto, Paolo Antonio
Publicado en Front Oncol (2015)

Anti-IL6R role in treatment of COVID-19-related ARDS

por Buonaguro, Franco Maria, Puzanov, Igor, Ascierto, Paolo Antonio
Publicado en J Transl Med (2020)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma

por Palmieri, Giuseppe, Puzanov, Igor, Massi, Daniela, Ascierto, Paolo Antonio
Publicado en Front Oncol (2021)

Tumor biobanks in translational medicine

por Botti, Gerardo, Franco, Renato, Cantile, Monica, Ciliberto, Gennaro, Ascierto, Paolo Antonio
Publicado 2012

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy

por Capone, Imerio, Marchetti, Paolo, Ascierto, Paolo Antonio, Malorni, Walter, Gabriele, Lucia
Publicado en Front Immunol (2018)

NF-κB as potential target in the treatment of melanoma

por Madonna, Gabriele, Ullman, Claudio Dansky, Gentilcore, Giusy, Palmieri, Giuseppe, Ascierto, Paolo Antonio
Publicado 2012

Evolving impact of long-term survival results on metastatic melanoma treatment

por Michielin, Olivier, Atkins, Michael B, Koon, Henry B, Dummer, Reinhard, Ascierto, Paolo Antonio
Publicado en J Immunother Cancer (2020)

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

por Motti, Maria Letizia, Minopoli, Michele, Di Carluccio, Gioconda, Ascierto, Paolo Antonio, Carriero, Maria Vincenza
Publicado en Int J Mol Sci (2020)

Do BRAF inhibitors select for populations with different disease progression kinetics?

por Ascierto, Paolo Antonio, Simeone, Ester, Grimaldi, Antonio Maria, Curvietto, Marcello, Esposito, Assunta, Palmieri, Giuseppe, Mozzillo, Nicola
Publicado 2013

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

por Ziogas, Dimitrios C, Gkoufa, Aikaterini, Cholongitas, Evangelos, Diamantopoulos, Panagiotis, Anastasopoulou, Amalia, Ascierto, Paolo Antonio, Gogas, Helen
Publicado en J Immunother Cancer (2020)

Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave

por Atripaldi, Luigi, Sale, Silvia, Capone, Mariaelena, Montesarchio, Vincenzo, Parrella, Roberto, Botti, Gerardo, Ascierto, Paolo Antonio, Madonna, Gabriele
Publicado en J Transl Med (2021)

Nevoid melanoma of the vagina: report of one case diagnosed on thin layer cytological preparations

por Fulciniti, Franco, Ascierto, Paolo Antonio, Simeone, Ester, Bove, Patrizia, Losito, Simona, Russo, Serena, Gallo, Maria Stella, Greggi, Stefano
Publicado 2007

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors

por Mozzillo, Nicola, Caracò, Corrado, Marone, Ugo, Di Monta, Gianluca, Crispo, Anna, Botti, Gerardo, Montella, Maurizio, Ascierto, Paolo Antonio
Publicado 2013

Serious haematological toxicity during and after ipilimumab treatment: a case series

por Simeone, Ester, Grimaldi, Antonio Maria, Esposito, Assunta, Curvietto, Marcello, Palla, Marco, Paone, Miriam, Mozzillo, Nicola, Ascierto, Paolo Antonio
Publicado 2014

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

por Botticelli, Andrea, Zizzari, Ilaria, Mazzuca, Federica, Ascierto, Paolo Antonio, Putignani, Lorenza, Marchetti, Luca, Napoletano, Chiara, Nuti, Marianna, Marchetti, Paolo
Publicado en Oncotarget (2016)

MicroRNAs in melanoma development and resistance to target therapy

por Fattore, Luigi, Costantini, Susan, Malpicci, Debora, Ruggiero, Ciro Francesco, Ascierto, Paolo Antonio, Croce, Carlo M., Mancini, Rita, Ciliberto, Gennaro
Publicado en Oncotarget (2017)